ModivCare (MODV) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

MODV Stock Forecast


ModivCare stock forecast is as follows: an average price target of $24.50 (represents a 37.72% upside from MODV’s last price of $17.79) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

MODV Price Target


The average price target for ModivCare (MODV) is $24.50 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $30.00 to $16.00. This represents a potential 37.72% upside from MODV's last price of $17.79.

MODV Analyst Ratings


Buy

According to 2 Wall Street analysts, ModivCare's rating consensus is 'Buy'. The analyst rating breakdown for MODV stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

ModivCare Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 03, 2024Michael PetuskyBarrington--27.94%23.66%
Sep 17, 2024Brooks O'NeilLoop Capital Markets--124.22%68.63%
Sep 17, 2024Brooks O'NeilLake Street--123.38%68.63%
May 06, 2024Brooks O'NeilLake Street--85.19%181.06%
Apr 02, 2024Brooks O'NeilLoop Capital Markets--140.62%181.06%
Feb 23, 2024Robbie MarcusJ.P. Morgan---48.20%-10.06%
Row per page
Go to

The latest ModivCare stock forecast, released on Oct 03, 2024 by Michael Petusky from Barrington, set a price target of $22.00, which represents a 27.94% increase from the stock price at the time of the forecast ($17.20), and a 23.66% increase from MODV last price ($17.79).

ModivCare Price Target by Period


1M3M12M
# Anlaysts-36
Avg Price Target-$27.33$33.00
Last Closing Price$17.79$17.79$17.79
Upside/Downside-100.00%53.63%85.50%

In the current month, the average price target of ModivCare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to ModivCare's last price of $17.79. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Sep 17, 2024Lake StreetBuyBuyHold
May 06, 2024Lake StreetBuyUpgrade
Aug 03, 2022StephensOverweightInitialise
Row per page
Go to

ModivCare's last stock rating was published by Lake Street on Sep 17, 2024. The company gave MODV a "Buy" rating, the same as its previous rate.

ModivCare Financial Forecast


ModivCare Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
Revenue---------$686.92M$699.11M$662.31M$653.92M$647.78M$628.22M$574.48M$575.77M$493.06M$474.45M$453.61M$398.51M$320.62M$282.26M$367.29M$384.83M$393.38M$363.91M$367.81M
Avg Forecast$750.88M$741.16M$735.26M$727.23M$718.94M$711.28M$701.00M$663.86M$696.78M$698.68M$653.87M$628.40M$618.42M$593.47M$583.30M$565.77M$553.33M$499.60M$486.95M$486.32M$395.50M$341.98M$368.06M$386.20M$378.80M$364.40M$364.40M$356.90M
High Forecast$759.01M$749.19M$743.22M$735.10M$726.31M$716.71M$701.00M$663.86M$701.57M$713.43M$660.95M$635.20M$625.12M$593.47M$583.30M$565.77M$553.33M$499.60M$486.95M$486.32M$395.50M$341.98M$368.06M$386.20M$378.80M$364.40M$364.40M$356.90M
Low Forecast$742.97M$733.35M$727.50M$719.56M$711.57M$705.85M$701.00M$663.86M$693.93M$682.08M$646.97M$621.77M$611.90M$593.47M$583.30M$565.77M$553.33M$499.60M$486.95M$486.32M$395.50M$341.98M$368.06M$386.20M$378.80M$364.40M$364.40M$356.90M
# Analysts1111421136334444333333334444
Surprise %---------0.98%1.07%1.05%1.06%1.09%1.08%1.02%1.04%0.99%0.97%0.93%1.01%0.94%0.77%0.95%1.02%1.08%1.00%1.03%

ModivCare's average Quarter revenue forecast for Dec 23 based on 3 analysts is $696.78M, with a low forecast of $693.93M, and a high forecast of $701.57M. MODV's average Quarter revenue forecast represents a 1.43% increase compared to the company's last Quarter revenue of $686.92M (Sep 23).

ModivCare EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
# Analysts1111421136334444333333334444
EBITDA---------$41.28M$-147.24M$33.79M$32.66M$38.12M$47.90M$38.82M$4.26M$18.88M$39.57M$45.52M$26.42M$60.84M$59.08M$11.08M$-6.67M$17.59M$1.55M$5.59M
Avg Forecast$36.49M$36.02M$35.73M$35.34M$34.94M$34.57M$34.07M$42.90M$33.86M$33.96M$31.78M$39.00M$2.84M$37.54M$36.89M$35.46M$35.00M$31.60M$30.80M$36.41M$35.80M$21.63M$23.28M$24.43M$23.96M$23.05M$23.05M$22.57M
High Forecast$36.89M$36.41M$36.12M$35.73M$35.30M$34.83M$34.07M$51.48M$34.10M$34.67M$32.12M$46.80M$3.41M$37.54M$36.89M$42.55M$35.00M$31.60M$30.80M$43.70M$42.97M$21.63M$23.28M$24.43M$23.96M$23.05M$23.05M$22.57M
Low Forecast$36.11M$35.64M$35.36M$34.97M$34.58M$34.30M$34.07M$34.32M$33.73M$33.15M$31.44M$31.20M$2.27M$37.54M$36.89M$28.36M$35.00M$31.60M$30.80M$29.13M$28.64M$21.63M$23.28M$24.43M$23.96M$23.05M$23.05M$22.57M
Surprise %---------1.22%-4.63%0.87%11.49%1.02%1.30%1.09%0.12%0.60%1.28%1.25%0.74%2.81%2.54%0.45%-0.28%0.76%0.07%0.25%

3 analysts predict MODV's average Quarter EBITDA for Dec 23 to be $33.86M, with a high of $34.10M and a low of $33.73M. This is -17.96% lower than ModivCare's previous annual EBITDA (Sep 23) of $41.28M.

ModivCare Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
# Analysts1111421136334444333333334444
Net Income---------$-4.30M$-190.94M$-5.99M$-5.00M$-2.06M$5.38M$-165.00K$6.79M$-7.57M$13.67M$18.84M$-3.06M$38.80M$37.00M$16.10M$-6.06M$8.15M$-1.71M$582.00K
Avg Forecast$12.26M$9.83M$7.70M$2.92M$10.80M$8.79M$10.91M$347.11K$18.21M$15.86M$23.10M$315.55K$-24.19M$23.02M$20.23M$286.87K$23.09M$20.14M$18.27M$15.07M$-4.15M$20.19M$4.74M$3.98M$710.85K$6.54M$2.84M$4.98M
High Forecast$12.43M$9.97M$7.81M$9.22M$16.53M$8.91M$10.91M$416.53K$21.35M$23.15M$23.42M$378.66K$-19.35M$23.02M$20.23M$344.24K$23.09M$20.14M$18.27M$18.09M$-3.32M$20.19M$4.74M$3.98M$710.85K$6.54M$2.84M$4.98M
Low Forecast$12.09M$9.70M$7.59M$-3.37M$4.40M$8.67M$10.91M$277.69K$14.03M$10.43M$22.78M$252.44K$-29.03M$23.02M$20.23M$229.49K$23.09M$20.14M$18.27M$12.06M$-4.98M$20.19M$4.74M$3.98M$710.85K$6.54M$2.84M$4.98M
Surprise %----------0.27%-8.27%-18.97%0.21%-0.09%0.27%-0.58%0.29%-0.38%0.75%1.25%0.74%1.92%7.81%4.04%-8.52%1.25%-0.60%0.12%

ModivCare's average Quarter net income forecast for Sep 22 is $23.02M, with a range of $23.02M to $23.02M. MODV's average Quarter net income forecast represents a 327.60% increase compared to the company's last Quarter net income of $5.38M (Jun 22).

ModivCare SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
# Analysts1111421136334444333333334444
SG&A---------$70.14M$79.24M$79.71M$90.06M$75.89M$79.41M$76.81M$92.00M$68.05M$56.35M$54.87M$54.10M$34.44M$31.20M$20.80M$15.00M$15.98M$16.86M$19.40M
Avg Forecast$78.45M$77.44M$76.82M$75.98M$75.12M$74.32M$73.24M$83.84M$72.80M$73.00M$68.32M$76.22M$70.59M$62.01M$60.94M$69.29M$57.81M$52.20M$50.88M$43.90M$73.33M$35.73M$38.46M$40.35M$39.58M$38.07M$38.07M$37.29M
High Forecast$79.30M$78.28M$77.65M$76.80M$75.89M$74.88M$73.24M$100.61M$73.30M$74.54M$69.06M$91.46M$84.70M$62.01M$60.94M$83.15M$57.81M$52.20M$50.88M$52.68M$87.99M$35.73M$38.46M$40.35M$39.58M$38.07M$38.07M$37.29M
Low Forecast$77.63M$76.62M$76.01M$75.18M$74.35M$73.75M$73.24M$67.07M$72.50M$71.26M$67.60M$60.97M$56.47M$62.01M$60.94M$55.43M$57.81M$52.20M$50.88M$35.12M$58.66M$35.73M$38.46M$40.35M$39.58M$38.07M$38.07M$37.29M
Surprise %---------0.96%1.16%1.05%1.28%1.22%1.30%1.11%1.59%1.30%1.11%1.25%0.74%0.96%0.81%0.52%0.38%0.42%0.44%0.52%

ModivCare's average Quarter SG&A projection for Dec 23 is $72.80M, based on 3 Wall Street analysts, with a range of $72.50M to $73.30M. The forecast indicates a 3.79% rise compared to MODV last annual SG&A of $70.14M (Sep 23).

ModivCare EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
# Analysts1111421136334444333333334444
EPS---------$-0.30$-13.47$-0.42$-0.35$-0.15$0.38$-0.01$0.48$-0.54$0.97$1.33$-0.22$2.52$-0.98$1.00$-0.55$0.47$-0.22$-0.04
Avg Forecast$0.86$0.69$0.54$0.20$0.76$0.62$0.77$0.27$1.28$1.11$1.62$1.49$1.56$1.62$1.42$1.43$1.62$1.42$1.28$1.60$1.52$1.42$0.33$0.28$0.05$0.46$0.20$0.35
High Forecast$0.87$0.70$0.55$0.65$1.16$0.63$0.77$0.27$1.50$1.62$1.64$1.53$1.58$1.62$1.42$1.44$1.62$1.42$1.28$1.60$1.52$1.42$0.33$0.28$0.05$0.46$0.20$0.35
Low Forecast$0.85$0.68$0.53$-0.24$0.31$0.61$0.77$0.27$0.98$0.73$1.60$1.46$1.53$1.62$1.42$1.43$1.62$1.42$1.28$1.60$1.52$1.42$0.33$0.28$0.05$0.46$0.20$0.35
Surprise %----------0.27%-8.31%-0.28%-0.23%-0.09%0.27%-0.01%0.30%-0.38%0.75%0.83%-0.14%1.77%-2.94%3.57%-11.00%1.02%-1.10%-0.11%

According to 4 Wall Street analysts, ModivCare's projected average Quarter EPS for Sep 22 is $1.62, with a low estimate of $1.62 and a high estimate of $1.62. This represents a 326.06% increase compared to MODV previous annual EPS of $0.38 (Jun 22).

ModivCare Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
SGRYSurgery Partners--77.31%Buy
HCSGHealthcare Services Group--48.37%Hold
INNVInnovAge--39.06%Hold
MODVModivCare--37.72%Buy
EHABEnhabit--35.58%Hold
MDPediatrix Medical Group--21.46%Hold
PNTGPennant Group--11.34%Buy
ENSGEnsign Group--1.26%Buy
SEMSelect Medical--0.83%Buy
EHCEncompass Health---4.07%Buy

MODV Forecast FAQ


Is ModivCare a good buy?

Yes, according to 2 Wall Street analysts, ModivCare (MODV) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of MODV's total ratings.

What is MODV's price target?

ModivCare (MODV) average price target is $24.5 with a range of $16 to $30, implying a 37.72% from its last price of $17.79. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will ModivCare stock go up soon?

According to Wall Street analysts' prediction for MODV stock, the company can go up by 37.72% (from the last price of $17.79 to the average price target of $24.5), up by 68.63% based on the highest stock price target, and down by -10.06% based on the lowest stock price target.

Can ModivCare stock reach $30?

MODV's average twelve months analyst stock price target of $24.5 does not support the claim that ModivCare can reach $30 in the near future.

What are ModivCare's analysts' financial forecasts?

ModivCare's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $2.8B (high $2.81B, low $2.78B), average EBITDA is $146.48M (high $155.68M, low $137.28M), average net income is $30.84M (high $36.76M, low $24.25M), average SG&A $306.51M (high $324.62M, low $288.41M), and average EPS is $2.41 (high $2.82, low $1.95). MODV's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $2.95B (high $2.99B, low $2.92B), average EBITDA is $143.59M (high $145.15M, low $142.08M), average net income is $32.71M (high $39.42M, low $26.01M), average SG&A $308.69M (high $312.04M, low $305.44M), and average EPS is $2.29 (high $2.77, low $1.82).

Did the MODV's actual financial results beat the analysts' financial forecasts?

Based on ModivCare's last annual report (Dec 2022), the company's revenue was $2.5B, beating the average analysts forecast of $2.36B by 6.08%. Apple's EBITDA was $157.5M, beating the average prediction of $112.73M by 39.71%. The company's net income was $-1.842M, missing the average estimation of $19.34M by -109.52%. Apple's SG&A was $322.17M, beating the average forecast of $262.82M by 22.58%. Lastly, the company's EPS was $-0.13, missing the average prediction of $6.03 by -102.16%. In terms of the last quarterly report (Sep 2023), ModivCare's revenue was $686.92M, missing the average analysts' forecast of $698.68M by -1.68%. The company's EBITDA was $41.28M, beating the average prediction of $33.96M by 21.56%. ModivCare's net income was $-4.302M, missing the average estimation of $15.86M by -127.12%. The company's SG&A was $70.14M, missing the average forecast of $73M by -3.91%. Lastly, the company's EPS was $-0.3, missing the average prediction of $1.11 by -126.95%